Finance

Lists
CNMD:NYSE
Conmed Corp
$49.98
-0.68%
(-0.34) 1D
$49.98
0.00% (0.00)
After hours
Closed: Aug 28, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNMD...
Open
$50.20
High
$51.12
Low
$49.87
Mkt. cap
1.50B
Avg. vol.
485.31K
Volume
216.41K
P/E ratio
27.06
52-wk high
$56.64
52-wk low
$31.44
EPS
$1.85
Beta
0.88
Shares outstanding
29.95M
No. of employees
4K
Open
$50.20
High
$51.12
Low
$49.87
Mkt. cap
1.50B
Avg. vol.
485.31K
Volume
216.41K
P/E ratio
27.06
52-wk high
$56.64
52-wk low
$31.44
EPS
$1.85
Beta
0.88
Shares outstanding
29.95M
No. of employees
4K
News stories
From web sources and news partners
About Conmed Corp
CEOCurt R. Hartman
Employees3.9K
Founded1970
HeadquartersLargo, Florida, United States
SectorMedical device
Websiteconmed.com
Analyst ratings
Based on 6 analysts giving stock ratings to CNMD in the past 3 months
Hold
Buy
0
Hold
5
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CNMD in the last 3 months.
Highest
Current $49.98
$46.00 (-7.96%)
Average
$45.25 (-9.46%)
Lowest
$45.00 (-9.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Sell
Maintained
-
-
07/30/2026
Robbie Marcus
J.P. Morgan
Hold
Reiterated
$45.00
-10%
07/30/2026
Vik Chopra
BMO Capital
Hold
Maintained
$45.00
-10%
07/29/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$46.00
-8%
07/30/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
$45.00
-10%
07/30/2026
Michael Matson
Needham
Hold
Maintained
-
-
07/30/2026
Unknown Analyst
BMO Capital
Hold
Initiated
$36.00
-28%
07/09/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.38 / $1.11
+24.33%beat
Revenue / Est. (USD)
343.49M / 337.54M
+1.76%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
0.85%
4.49%
4.36%
6.72%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps